Literature DB >> 7756916

Prescribing benzodiazepines for noninstitutionalized elderly.

M Thomson1, W A Smith.   

Abstract

OBJECTIVE: To describe benzodiazepine prescribing for elderly people living in the community in British Columbia, and to compare such prescribing with an indicator of current guidelines.
DESIGN: Descriptive analysis of pharmacy billing data.
SETTING: Province of British Columbia. PARTICIPANTS: All elderly persons (age 65 and older) dispensed benzodiazepines by community pharmacies in British Columbia during 1990. MAIN OUTCOME MEASURE: Potentially inappropriate prescriptions were defined by a maximum 2-month limit of 20 diazepam equivalents daily, as determined by the BC Drug Usage Review Program in consultation with experts in the field. Physicians' rates of potentially inappropriate prescribing were determined per 100 benzodiazepine prescriptions written.
RESULTS: Almost 24% of elderly people in British Columbia were prescribed benzodiazepines at least once during 1990. Of these, 17.1% were given potentially inappropriate prescriptions. Physicians who prescribed benzodiazepines most frequently had the highest rates of potentially inappropriate prescriptions.
CONCLUSION: Prescribing practice does not correspond with our indicator of current guidelines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756916      PMCID: PMC2146615     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  Drug usage review. Part one: designing the BC Pharmacare program.

Authors:  J N Hlynka; D H Danforth
Journal:  Can Pharm J       Date:  1981-11

2.  The long and the short of sleeping pills.

Authors:  J C Gillin
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

Review 3.  Management of drug therapy in the elderly.

Authors:  S C Montamat; B J Cusack; R E Vestal
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

4.  The Saskatchewan program for rational drug therapy: effects on utilization of mood-modifying drugs.

Authors:  J L Blackburn; F W Downey; T J Quinn
Journal:  DICP       Date:  1990-09

5.  The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs.

Authors:  E Hemminki
Journal:  Med Care       Date:  1974-04       Impact factor: 2.983

6.  The relationship between physician characteristics and prescribing appropriateness.

Authors:  P D Stolley; M H Becker; L Lasagna; J D McEvilla; L M Sloane
Journal:  Med Care       Date:  1972 Jan-Feb       Impact factor: 2.983

7.  Psychotropic drug use among women.

Authors:  R Cooperstock
Journal:  Can Med Assoc J       Date:  1976-10-23       Impact factor: 8.262

8.  The effects of non-prescribing of anxiolytics in general practice. I. Controlled evaluation of psychiatric and social outcome.

Authors:  J Catalan; D Gath; G Edmonds; J Ennis
Journal:  Br J Psychiatry       Date:  1984-06       Impact factor: 9.319

9.  Improving benzodiazepine prescribing in family practice through review and education.

Authors:  W W Rosser; J G Simms; D W Patten; J Forster
Journal:  Can Med Assoc J       Date:  1981-01-15       Impact factor: 8.262

  9 in total
  4 in total

Review 1.  Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients.

Authors:  D B Hogan
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

2.  High daily doses of benzodiazepines among Quebec seniors: prevalence and correlates.

Authors:  M Y Egan; C Wolfson; Y Moride; J Monette
Journal:  BMC Geriatr       Date:  2001       Impact factor: 3.921

3.  Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies.

Authors:  Philippe Voyer; David Cohen; Sylvie Lauzon; Johanne Collin
Journal:  BMC Nurs       Date:  2004-08-13

4.  The cascade of benzodiazepine prescribing for hospitalized geriatric patients.

Authors:  Neshahthari Wijeyakuhan; Rachel Gruber; Nicholas A Rattray
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.